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Abstract
Visual perceptual problems are common in Parkinson's disease (PD) and often affect activities of
daily living (ADLs). PD patients with non-tremor symptoms at disease onset (i.e., rigidity,
bradykinesia, gait disturbance or postural instability) have more diffuse neurobiological
abnormalities and report worse non-motor symptoms and functional changes than patients whose
initial symptom is tremor, but the relation of motor symptom subtype to perceptual deficits
remains unstudied. We assessed visual ADLs with the Visual Activities Questionnaire in 25 non-
demented patients with PD, 13 with tremor as the initial symptom and 12 with an initial symptom
other than tremor, as well as in 23 healthy control participants (NC). As expected, the non-tremor
patients, but not the tremor patients, reported more impairment in visual ADLs than the NC group,
including in light/dark adaptation, acuity/spatial vision, depth perception, peripheral vision and
visual processing speed. Non-tremor patients were significantly worse than tremor patients overall
and on light/dark adaptation and depth perception. Environmental enhancements especially
targeted to patients with the non-tremor PD subtype may help to ameliorate their functional
disability.
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Introduction
Parkinson's disease (PD) has traditionally been viewed as a movement disorder
characterized by resting tremor, rigidity, bradykinesia, and postural instability, but non-
motor symptoms of the disease are also experienced by the majority of patients (∼83%;
Shulman, Taback, Bean, & Weiner, 2001) including disorders of sensation and perception,
mood, sleep, and cognition (for recent reviews, see Chaudhuri & Schapira, 2009; Cronin-
Golomb, 2010; Pandya, Kubu, & Giroux, 2008; Poewe, 2008). These non-motor symptoms
are as debilitating as the motor symptoms and may actually be better predictors of quality of
life (Witjas et al., 2002). Patients with worse non-motor symptoms report more impairments
in overall daily functioning (Hariz & Forsgren, 2011). Objective measures of non-motor
symptoms, such as visual testing, have been found to relate to performance on certain
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activities of daily living (ADL), such as driving a car (Amick, Grace, & Ott, 2007; Uc,
Rizzo, Johnson, et al., 2009). Visual perceptual deficits are of particular relevance to vision-
based ADLs.
Patients with PD exhibit an array of visual perceptual deficits, ranging from problems with
basic abilities such as detecting color (Buttner et al., 1993; Diederich, Raman, Leurgans, &
Goetz, 2002; Lee & Harris, 1999; Price, Feldman, Adelberg, & Kayne, 1992) and perception
of planar motion and optic flow (Davidsdottir, Wagenaar, Young, & Cronin-Golomb, 2008)
to higher-order abilities such as facial emotion recognition (Clark, Neargarder, & Cronin-
Golomb, 2008) and facial scanning (Clark, Neargarder, & Cronin-Golomb, 2010).
Numerous studies indicate that patients with PD experience deficits in contrast sensitivity. In
an early report, Bodis-Wollner and Yahr (1978) found that patients with PD displayed
greater latencies to visual evoked potentials than did a control group in response to
sinusoidal contrast gratings, providing initial evidence for visual perceptual deficits.
Reduced contrast sensitivity in PD has since been reported using low-contrast letter reading
charts (e.g., Regan & Neima, 1984; Regan & Maxner, 1987) and computer-based measures
(e.g., Amick, Cronin-Golomb, & Gilmore, 2003; Davidsdottir et al., 2008). These changes in
contrast sensitivity are not benign as they have been related to quality of life in PD. For
example, poor contrast sensitivity is associated with worse driving performance (Amick et
al., 2007; Devos et al., 2007; Uc, Rizzo, Anderson, et al., 2009; Worringham, Wood, Kerr,
& Silburn, 2006) and with motor freezing and hallucinations (Davidsdottir, Cronin-Golomb,
& Lee, 2005).
In addition to deficits in basic visual functioning, patients with PD experience problems with
higher-level visuospatial functioning, which may affect performance on ADLs. Visuospatial
functioning includes perceiving the spatial relations among visual stimuli, a skill necessary
to performing everyday tasks such as preparing meals, driving a car, and selecting
medications. Experimental studies have shown that several aspects of visuospatial
functioning are impaired in PD, including spatial navigation, mental rotation, hierarchical
pattern perception, facial emotion recognition, spatial working memory and spatial planning
(Altgassen, Phillips, Kopp, & Kliegel, 2007; Amick, Schendan, Ganis, & Cronin-Golomb,
2006; Clark et al., 2008; Cronin-Golomb, 2010; Davidsdottir et al., 2008; Kemps, Szmalec,
Vandierendonck, & Crevits, 2005; Lee, Harris, & Calvert, 1998; Montse, Pere, Carme,
Francesc, & Eduardo, 2001; Possin, Filoteo, Song, & Salmon, 2008; Schendan, Amick, &
Cronin-Golomb, 2009; Siegert, Weatherall, Taylor, & Abernethy, 2008). These findings are
in line with studies using self-report measures, through which PD patients report problems
judging distances (Davidsdottir et al., 2005; Lee & Harris, 1999; McDowell & Harris,
1997a). The relation between these visuospatial changes and performance on a variety of
everyday tasks is less clear. Klepac, Trkulja, Relja, and Babić (2008) reported that better
performance on neuropsychological tests of visuospatial and executive functioning were
related to better health-related quality of life as indicated by self report (Parkinson's Disease
Questionnaire; PDQ-39). Studies using more naturalistic designs have reached similar
conclusions. For example, Uc and colleagues (2007) examined the relation between driving
and neuropsychological performance. They found that performance on visuospatial and
executive functioning tasks but not on tasks of motor function predicted driving
performance, suggesting that the non-motor symptoms of PD are at least as detrimental to
everyday functioning as the motor symptoms.
PD is described as a heterogeneous disorder in many respects, including in terms of
perceptual abilities, and this heterogeneity may be related to daily function. Attention is
being turned increasingly to the type of initial symptom of PD (Lewis et al., 2005) as a
major source of heterogeneity, with differences emerging between patients presenting with
resting tremor versus non-tremor symptoms. The non-tremor subtype is also referred to as
Seichepine et al. Page 2
J Int Neuropsychol Soc. Author manuscript; available in PMC 2013 September 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
akinetic-rigid or postural instability-gait difficulty (PIGD; Zaidel, Arkadir, Israel, &
Bergman, 2009). Multiple single-photon emission studies have demonstrated negative
correlations between striatal uptake of dopamine and non-tremor symptoms (i.e., rigidity,
bradykinesia, gait, balance, and posture) but not tremor symptoms, indicating that these two
types of motor symptoms likely arise from disturbances of different neural systems
(Benamer et al., 2000; Brücke et al. 1997; Seibyl et al., 1995; Shinotoh, Uchida, Ito, &
Harrori, 2000; Spiegel et al., 2007). These findings have been further supported by post-
mortem studies indicating more diffusely located cortical Lewy bodies (Selikhova,
Williams, Kempster, Holton, & Lees, 2009) and greater dopamine loss within the ventral
rostral region of the globus pallidus in cases with non-tremor onset relative to tremor-onset
(Rajput et al., 2008). In regard to clinical presentation, non-tremor onset patients experience
faster disease progression and more frequent dyskinesias, gait disorders and falls (Rudzinska
et al., 2007). They appear to be more susceptible to non-motor symptoms than the tremor-
onset subtype (Reijnders, Ehrt, Lousberg, Aarsland, & Leentjens, 2009), including slower
psychomotor speed and decreased cognitive flexibility (Lyros, Messinis, &
Papathanasopoulos, 2008), procedural learning (Vakil & Herichanu-Naaman, 1998),
attentional decline (Taylor et al., 2008), more frequent dementia (Alves, Larson, Emre,
Wentzel-Larson, & Aarsland, 2006; Burn et al., 2006; Burn et al., 2003; Rajput, Voll,
Rajput, Robinson, & Rajput, 2009), and more frequent depression (Burn et al., 2003; Lewis
et al., 2005). Additionally, non-tremor onset patients have reported poorer ADLs than
tremor onset patients (Hariz et al., 2011). Visual-based ADLs (everyday activities performed
for self-care that rely on visual functioning) have not yet been examined for these subtypes
of PD.
Previous reports linking visual deficits to impaired functional performance in PD have
primarily focused on contrast sensitivity and on driving competence in PD without reference
to subtypes. The present study expands the scope of investigation by using visual
assessments together with a validated self-report measure (Visual Activities Questionnaire;
VAQ) to identify the extent to which visual ADLs are compromised by PD and to determine
which specific visual domains are most affected in the tremor and non-tremor PD subtypes.
We hypothesized that the non-tremor onset subtype would report more problems with visual
ADLs, consistent with recent evidence suggesting that this subtype experiences a wide range
of non-motor symptoms, including difficulties with ADLs in general. A better understanding
of visual deficits and the visual ADL domains affected may point to specific interventions to
improve ADLs and quality of life in PD.
Method
Participants
Participants included 25 individuals with PD (12 women, 13 men) and 23 age and
education-matched normal control participants (NC; 11 women, 12 men). The PD
participants were grouped by type of initial motor symptom: tremor dominant onset (TD; 6
women, 7 men) or non-tremor dominant onset (NTD; 6 women, 6 men). Five of the NTD
subtype participants had initial symptoms starting on the left side of the body and seven had
symptoms starting on the right side of the body. In the TD subtype, seven participants' initial
symptoms were on the left side and six on the right side. Demographic characteristics were
similar between participants with respect to side of initial symptom. Characteristics of the
TD and NTD subtypes are listed in Table 1. All participants provided informed consent for
the protocol approved by the Boston University Charles River Campus Institutional Review
Board.
PD patients were recruited from the Parkinson's Disease Clinic of Boston Medical Center.
NC participants were recruited from the general community. Exclusion criteria included
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coexisting serious chronic medical illnesses (including psychiatric or neurological), use of
psychoactive medications besides anti-depressants and anxiolytics in the PD group, use of
any psychoactive medications in the NC group, history of intracranial surgery, traumatic
brain injury, alcoholism or other drug abuse, or eye disease or abnormalities as noted on an
eye examination. Seventeen of the 23 NC and 17 of the 25 PD participants received a
detailed neuro-ophthalmological examination to rule out visual disorders arising from
dysfunction of anterior pathways, including cataracts, glaucoma, and macular degeneration.
There were no differences between those who completed the neuro-ophthalmological
examination and those who did not on any of the visual measures or the VAQ. Participants
used their own refractive correction for all testing.
The groups were matched for age, education, and male:female ratio. No participants were
demented, with all obtaining scores of 27 or above on the standard Mini-Mental State
Examination (four NC) or 25 or above on the Modified Mini-Mental State Examination (all
other participants; overall scores converted to the standard MMSE scale). Because the
Modified MMSE includes items that are sensitive to PD-based cognitive problems in the
absence of dementia, we used a cut-off score of 25 rather than the standard MMSE cut-off of
27. Mean scores for both the tremor onset subtype (27.4; SD = .82) and non-tremor onset
subtype (28.0; SD = 1.5) were worse than for the NC group (28.9, SD =.73).
Analyses of the Modified MMSE subscales were conducted to examine potential cognitive
differences between groups and post hoc comparisons were corrected to .017 for the number
of groups (.05/3). All groups performed similarly on orientation (p = .99), registration (all
groups performed without error), recall (p = .12), general knowledge (p = .46), confrontation
naming (p = .67), language (p = .09), and construction (p = .23) (performance near ceiling in
all cases). The TD group had lower scores on digit span than the NC group (p < .017); NTD
and NC participants received the maximum subscale score (10 of 10). The digit span
subscale of the Modified MMSE differs from traditional digit span scores as up to only 10
points can be awarded (up to 6 for digits forward and up to 4 for digits backward). NTD
patients performed more poorly than NC on attention and concentration (i.e., serial sevens
and adding change; p < .017), and there was a trend for TD patients to perform more poorly
than NC (p = .03). There was no difference between the two PD groups (p = .82).
In addition to MMSE, verbal fluency (category-animals and letter “F”) and traditional
(longest) digit span forward and backward were also assessed for the PD participants. The
TD and NTD groups performed similarly on both measures of verbal fluency and on longest
digit span backward, but the TD group performed more poorly than the NTD group on
longest digit span forward (p < .05).
PD patients endorsed more depressive symptoms on the Geriatric Depression Scale (GDS;
Yesavage et al., 1983) than the NC (t (46) = 2.7; p < .01). Patients with the tremor onset and
non-tremor onset subtypes indicated similar levels of depression (t(23) = 0.3; p = .77). PD
participants had mild to moderate motor symptoms as indicated by a median stage II Hoehn
and Yahr score (Hoehn & Yahr, 1967) with a stage range of I to III. Motor scores on the
Unified Parkinson's Disease Rating Scale (UPDRS) ranged from 9 to 48 with a mean of 35.1
(SD = 10.6) for the TD group and 25.7 (SD = 10.4) for the NTD group (t(23) = 2.2, p < .04),
indicating that the TD group had worse overall motor scores. Motor symptom scores for the
rigidity, bradykinesia, gait, and tremor subscales were similar for the PD subgroups. The
mean duration of illness was similar for NTD (8.6 years) and TD (8.9 years). Overall, the
TD group had more severe motor symptoms (as indicated by UPDRS total motor score) than
the NTD group, despite the groups being similar in cognitive performance. All participants
were tested while they were in the “on” stage of medication effectiveness. For PD, levodopa
equivalent dosages (LED) were calculated based on previous reports with LED: (regular
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levodopa dose × 1) + (levodopa controlled-release does × .75) + (pramipexole dose × 67.0)
+ ropinirole dose × 16.67) + (rotigotine × 16.67) + (pergolide dose and cabergoline dose ×
67.0) + (bromocriptine dose × 10) + ([regular levodopa dose +levodopa controlled-release
dose × .75] × .25) if taking tolcapone or entacapone. Mean LED was 545.4 mg (standard
deviation = 329.6). Of 21 PD patients who provided details of their medications, 17 (81%)
were on a combination of carbidopa and levodopa and 17 patients (81%) were also taking a
DA agonist including three of the four who were not on a combination carbidopa/levodopa
medication. Overall, 20 of the 21 participants (95%) were on one or both of these
medications. PD symptoms in the remaining participant were being treated with an MAO
inhibitor (selegiline). Five patients were on a COMT inhibitor (mean = 575 mg; standard
deviation = 419.3 mg).
Measures and Procedures
Participants were administered the VAQ and several measures of basic visual functioning.
Visual functioning was assessed at both near and far distances because deficits may occur at
one distance and not the other, and these differences may relate to different types of visual
ADLs. For example, deficits at closer distances may affect reading, whereas deficits at
farther distances may affect driving.
Acuity—Snellen eye charts (Lighthouse, Long Island City, New York) were used to
measure binocular visual acuity at 10 feet for far acuity and 16 inches to the corner of the
eye for near acuity. Participants read a series of progressively smaller letters starting at the
top row (largest) and move down until they can no longer identify one half of the letters on
that row. Standard Snellen scores (minimal angle of resolution) were log-transformed to
perform group comparisons.
Contrast Sensitivity—was assessed binocularly with near (16 inches) and far (10 ft)
Functional Acuity Contrast Test Charts (FACT: Stereo Optical, Chicago, IL). The FACT
assesses the degree of contrast at which an individual can correctly detect the orientation of
sinusoidal gratings at various spatial frequencies. The stimuli are presented in nine rows of
circles that decrease in contrast from left to right. Moving down each column, the gratings
increase in spatial frequency, from 1.5, 3, 6, 12, to 18 cycles per degree (cpd). In each circle,
the gratings are oriented either vertically, to the left, or to the right and the participant
indicates the orientation, either verbally or by hand gesture. A contrast level is determined
for each spatial frequency by finding the minimal perceptible contrast level required to
correctly identify the orientation of the grating for a given row. Higher scores indicate better
contrast sensitivity. Participants who could not recognize the highest contrast level for each
spatial frequency were excluded from analysis.
The Visual Activities Questionnaire—(Sloane, Ball, Owsley, Bruni, & Roenker, 1992)
is a 33-item self-report measure of the effect of vision on performing everyday tasks.
Participants are provided the following instructions printed on the top of the questionnaire:
“On the next few pages you'll read some statements about problems you may encounter
during activities which involve vision. Read each statement carefully. Then indicate how
frequently you have the problem, by choosing the word beneath the statement that best
applies to you and your situation. Please answer all the questions as if you were wearing
your glasses or contact lenses (if any).” For each statement, participants place a mark to
indicate the frequency at which problems occur on a five-point scale: never, rarely,
sometimes, often, or always. On the five items that ask about driving a car, participants can
also mark “do not drive” and these scores are removed from subscale calculations. Higher
scores indicate worse visual functioning. Items load onto one of eight subscales: color
discrimination (three items), glare disability (three items), light/dark adaptation (four items),
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acuity/spatial vision (four items), depth perception (three items), peripheral vision (five
items), visual search (five items), and visual processing speed (six items). Participants were
provided as much time as required to complete the questionnaire.
Results
Visual Functioning by Group
Acuity scores were similar among the three groups at both near (F(2,45) = 0.9; p = .42) and
far (F(2,45) = 1.6; p = .21) distances.
Near FACT—The FACT contrast sensitivity test provides data at specific cycles per degree
(cpd). For near FACT, four PD participants (three non-tremor onset) could not see even the
highest contrast level at the highest spatial frequency, 18 cpd. Accordingly, data were
analyzed for the first four spatial frequencies (1.5, 3.0, 6.0, and 12.0 cpd) using a mixed
design ANOVA and at the highest spatial frequency (18.0 cpd) using an independent groups
t test. By analyzing the data separately we avoided the elimination of the four participants'
data in the frequencies below 18.0 cpd. A one-tailed mixed design analysis of variance
(ANOVA) with group serving as the between group factor (NC, TD, and NTD) and
frequency (1.5, 3.0, 6.0, 12.0 cpd) serving as the within group factor indicated a significant
main effect of spatial frequency (F(2.2, 95.7) = 94.8; p < .001), a significant main effect of
group (F(2,44) = 6.7; p < .002), and a significant interaction between group and spatial
frequency (F(4.4, 95.7 = 3.0; p < .01). Post hoc analyses for the interaction indicated that the
NTD group had reduced contrast sensitivity relative to NC at 3.0 cpd (p < .02), 6.0 cpd (p < .
01), and 12.0 cpd (p < .002), and relative to the TD group at 3.0 cpd (p < .02) and 12.0 cpd
(p < .04). NC and the TD group performed similarly to each other across spatial frequencies.
For the 18.0 cpd condition, there were no significant differences between groups (F(2,41) =
1.9; p = .08).
Far FACT—For the far FACT, one NTD and two NC participants could not see the highest
contrast level at 18.0 cpd, and data were, therefore, analyzed separately as described above.
This is typical of normal aging (reviewed in Owsley, 2010). For the first four spatial
frequencies, we observed a significant main effect of spatial frequency (F(2.7, 121.4) = 73.8;
p < .001), and a significant main effect of group (F(2,42) = 2.8; p < .04), but no interaction
between group and spatial frequency (F(5.4, 121.4) = .60; p = .38). After correcting for
multiple comparisons, post hoc analyses were not significant for any comparison. For the
18.0 cpd condition, there was a significant difference between groups (F(2, 42) = 2.6; p < .
04), however, corrected post hoc analyses did not reveal any notable differences between the
three groups.
Statistical analyses of the VAQ—Non-parametric statistics were used to perform all
analyses. Effects of group (TD, NTD, NC) were examined by the Kruskall-Wallis test and
when indicated (alpha ≤.05), post hoc analyses were performed (Mann-Whitney U test). Post
hoc analyses were adjusted for multiple comparisons using Bonferroni's correction (.05/3 = .
017). Spearman rank correlation coefficients were used to determine dependence between
variables. Although individuals with PD endorsed more depressive symptoms on the
Geriatric Depression Scale than did NC, results were not correlated with performance on
any of the VAQ subscales for either group, indicating that depression differences were not
responsible for the significant group findings.
Scores on the VAQ by group—The Kruskall-Wallis test revealed significant
differences by group (NC, TD, NTD) on the overall composite score (H(2) = 8.9; p < .05).
Post hoc analyses were adjusted for multiple comparisons using Bonferroni's correction and
Seichepine et al. Page 6
J Int Neuropsychol Soc. Author manuscript; available in PMC 2013 September 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
indicated that the NTD group endorsed more problems than either the NC group (U = 62.0;
p < .017) or the TD group (U = 30.0; p < .017). There was no difference in scores between
NC and the TD group (U = 130; p = .54). Medium to large effect sizes were observed for the
NTD group compared to NC (r = −.45) and the NTD group compared to TD group (r = −.52)
(Figure 1).
Analyses of the eight subscales by group—Kruskall-Wallis tests were performed at
each subscale to examine potential group differences. Significant group differences were
observed on the subscales for light/dark adaptation (H(2) = 8.4; p < .05), acuity/spatial
vision (H(2) = 6.1; p < .05), depth perception (H(2) = 9.3; p < .01), peripheral vision (H(2) =
9.7; p < .01), and visual processing speed (H(2) = 7.7; p < .05). Post hoc analyses were
performed and were adjusted for multiple comparisons using Bonferroni's correction. There
were no significant differences in scores between the NC and TD group. The NTD group
endorsed more problems than the NC group on light/dark adaptation (U = 65.5; p < .017),
acuity/spatial vision (U = 69.5; p < .017) depth perception (U = 62.0; p < .017), peripheral
vision (U = 56.5; p < .017) and visual processing speed (U = 66.5; p < .017). When
compared to the TD group, the NTD group endorsed more problems on light/dark adaptation
(U = 31.0; p < .017) and depth perception (U = 33.0; p < .017). Effect size analyses were
performed when appropriate using Pearson's correlation coefficient. Medium to large effect
sizes were observed for the NTD group compared to the NC on light/dark adaptation (r = −.
43), acuity/spatial vision (r = −.40), depth perception (r = −.47), peripheral vision (r = −.49),
and visual processing speed (r = −.42). Large effect sizes were observed for the NTD group
compared the TD group on light/dark adaptation (r = −.52) and depth perception (r = −.51).
See Figure 2.
Correlations between VAQ scores and vision results—Correlations between vision
scores and the VAQ were determined by Spearman rank correlation coefficients for NC and
for the two PD subgroups. All significant correlations are shown in Table 2. For analyses,
FACT levels were grouped according to whether they were low (1.5, 3.0 cpd), middle (6.0,
12.0 cpd), or high spatial frequencies (18.0 cpd). Lower scores on the FACT indicate worse
contrast sensitivity and higher scores on the VAQ indicate more problems with visual
ADLs; hence, negative correlations indicate more problems with visual ADLs with poorer
contrast sensitivity. All correlations for the NC group were negative, as expected. No
correlations were significant for the NT group. For the tremor-onset group, correlations with
the acuity/spatial vision subscale were negative; correlations with other subscales were
positive. In light of the number of correlations and the resulting limitation of statistical
power, these comparisons should be considered exploratory in nature.
Discussion
We found that PD patients without tremor as the initial symptom experienced more
problems with visual ADLs than did either PD patients with tremor as the initial symptom or
healthy control adults. This finding is consistent with recent evidence suggesting that non-
tremor onset PD is associated with a wide range of non-motor symptoms and problems with
ADLs in general. Group differences were observed between the non-tremor onset patients
and the NC group in five of the eight visual domains tested by the VAQ, including light/dark
adaptation, acuity/spatial vision, depth perception, peripheral vision, and visual processing
speed. PD subtype differences were also observed, with the non-tremor patients reporting
more problems with light/dark adaptation and depth perception than the tremor subtype. By
contrast, PD participants with tremor as the initial symptom indicated levels of functioning
similar to the NC group in all visual ADL domains. This finding accords with reports
indicating that the tremor subtype experiences fewer and less severe non-motor symptoms of
PD than does the non-tremor subtype(Allcock, Kenny, & Burn, 2006; Burn et al., 2003;
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Hariz et al., 2011) and indicates that, in mild to moderate PD, visual ADLs are preserved in
the tremor subtype.
We also observed that the non-tremor subtype had worse near contrast sensitivity when
compared to either tremor onset PD or healthy control adults. Contrast sensitivity deficits in
PD have been reported consistently (Amick et al., 2003; Bodis-Wollner et al., 1987;
Davidsdottir et al., 2008; Diederich et al., 2002; Kupersmith, Shakin, Siegel, & Liberman,
1982; Pieri, Diederich, Raman, & Goetz, 2000; Regan and Neima, 1984; Regan and Maxner,
1987), but this is the first study to our knowledge indicating that these deficits are especially
pronounced in the non-tremor subtype. Further studies are needed to assess why the contrast
sensitivity deficit emerged at the near distance only. As with normal aging and other age-
related neurological disorders, the reduced signal strength stemming from deficits in visual
perception may impact cognition (Clay et al., 2009; Cronin-Golomb, Corkin, & Growdon,
1995; Cronin-Golomb, Gilmore, Neargarder, Morrison, & Laudate, 2007; Gilmore, Spinks,
& Thomas, 2006), thereby resulting in worse functional outcomes. In PD there is some
evidence that increasing contrast improves cognition and everyday functioning (Amick et
al., 2003; Uc, Rizzo, Anderson, et al., 2009). The results of the present study suggest that
further investigation of the effect of sensory deficits, particularly contrast sensitivity, on
cognition and everyday function by PD subtype is warranted.
Single photon emission computed tomography studies routinely demonstrate negative
correlations between striatal uptake of dopamine and the non-tremor symptoms of PD (i.e.,
rigidity, bradykinesia, gait, balance, and posture), but not tremor, suggesting that the non-
tremor symptoms (but not tremor) stem from deficits in the nigrostriatal dopaminergic
system. These findings are also observed when striatal dopamine levels are analyzed by
group (i.e., non-tremor PD vs. tremor PD; Spiegel et al., 2007). Some of the visual
perceptual deficits seen in PD, particularly contrast sensitivity, may be associated with
dopamine changes in the retina (for reviews, see Bodis-Wollner, 1990, 2009; Witkovsky,
2004). Consistent with these two lines of investigation, we observed contrast sensitivity
deficits in the PD subtype associated with greater striatal dopamine loss (non-tremor
subtype) relative to the PD subtype with the least striatal dopamine loss (tremor subtype).
This finding suggests that the non-tremor subtype may be associated with more significant
dopamine deficits in the retina than the tremor subtype, likely stemming from deficits in the
nigrostriatal system. Dopamine also plays a role in visual processing in posterior cortical
regions and it has been proposed that visual processing relies on a dopamine-dependent
circuit between the basal ganglia and the striate cortex (Silkis, 2007a; Silkas, 2007b).
Accordingly, contrast sensitivity deficits, especially in non-tremor onset PD, may also stem
from dopamine loss in posterior regions.
Light/Dark Adaptation
The light/dark adaption subscale of the VAQ reflects problems performing visual ADLs that
require adjusting to lighting conditions, such as going from a dark movie theater into
daylight. We found that non-tremor onset PD is associated with more problems adjusting to
these settings than both a well-matched control group and tremor-onset PD. This finding is
consistent with experimental studies indicating that patients with PD have deficits in pupil
reactivity, an autonomic function, in response to light adaptation (Micieli et al., 1991;
Verbaan et al., 2007), but suggest that this type of autonomic dysfunction may be more
pronounced in the non-tremor subtype. Autonomic dysfunction as indicated by orthostatic
hypotension has been previously shown to be worse in the non-tremor subtype (Allcock et
al., 2006). Further studies exploring the extent of autonomic dysfunction by PD subtype may
be warranted. It is unclear why the tremor onset group, unlike the other two groups, showed
a negative correlation between light–dark adaptation and acuity/contrast sensitivity. Follow-
up studies are planned to examine this finding.
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Acuity and Spatial Vision
The acuity/spatial vision subscale of the VAQ reflects problems performing visual ADLs
that require seeing fine detail, such as reading small print seen in phone books or
newspapers. Three of the four items are specific to reading text that is either small in size or
of low contrast and may, therefore, reflect difficulties with acuity and concentration.
Davidsdottir and colleagues (2005) found that over 40% of their sample of 81 PD patients
reported not being able to read as well as they used to, and they attributed these difficulties
to problems with vision and concentration. Consistent with this self-report, in the present
study we found that the scores of tremor-onset PD patients on the acuity/spatial vision
subscale correlated with performance on contrast sensitivity (FACT). In fact, the correlation
between performance on the acuity/spatial subscale and contrast sensitivity was in the
expected direction, with poorer acuity/spatial behavior associated with poorer contrast
sensitivity, whereas for the other subscales the correlation was of better acuity/spatial
behavior associated with poorer contrast sensitivity. These findings may reflect the known
individual variability of the relation between visual input and spatial navigation in PD, with
investigators attributing inconsistencies in the effectiveness of visual cues to compensate for
gait and postural abnormalities in PD to individual differences at the perceptual level (e.g.,
Azulay et al., 1996, 1999); to date, no studies have investigated this relation by PD subtype.
In our sample, the non-tremor subtype, but not the tremor subtype, had significantly worse
near contrast sensitivity (3.0, 6.0, and 12.0 cpd) than the NC group. Likewise we found
group differences on the acuity/spatial subscale of the VAQ between the non-tremor subtype
and NC. Taken together, these findings suggest that the worse contrast sensitivity in the non-
tremor subtype likely contributed to difficulties performing visual ADLs involving acuity/
spatial vision, particularly reading.
Depth Perception
The depth perception subscale of the VAQ reflects problems performing visual ADLs that
require appreciating the spatial relations between objects, such as judging the level of liquid
in a cup when pouring a cup of coffee. We found that non-tremor onset PD was associated
with more problems performing depth perception related ADLs than both the NC subtype
and tremor-onset PD patients. Visuospatial deficits in PD are well documented and have
been previously linked to side of motor symptom onset in PD (reviewed in Cronin-Golomb,
2010), but there is only limited evidence relating type of motor symptom to visuospatial
performance. Maeshima and colleagues (1997) reported that PD patients with visuospatial
deficits (as indicated by cube copying) had more bradykinesia (as indicated by alternating
hand movements) than PD patients without visuospatial deficits. Our findings are consistent
with those of these investigators in that PD patients with non-tremor onset, including those
presenting with bradykinesia, indicated more problems with visual ADLs involving depth
perception.
Peripheral Vision
The peripheral vision subscale of the VAQ reflects problems performing visual ADLs that
require detecting and orienting to stimuli in the periphery, such as changing lanes in traffic
due to problems seeing cars in the next lane. Difficulties with peripheral vision-related
ADLs in the non-tremor subtype may stem from the more extensive akinesia, rigidity, and
bradykinesia in this group, which affect initiation and speed of voluntary movements.
Deficits in attentional systems may also contribute to problems with peripheral vision-
related ADLs. In a series of experiments, McDowell and Harris (1997b) examined reaction
time in response to a centered visual cue displayed on a computer monitor with and without
additional stimuli in the periphery. Time to initiate movement (i.e., latency from start signal
to release of finger from a touch pad) in PD was similar to that of control participants when
the peripheral field was blank (e.g., a solid color). When the peripheral field contained
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additional stimuli including stationary and moving objects, however, PD participants were
slower to initiate movement than the control group. Follow-up experiments indicated that
this delay in motor action was particularly pronounced when appearance (or disappearance)
of peripheral stimuli occurred near the onset of the visual cue that signaled that a motor
response was required. These findings are particularly relevant to certain visual ADLs, such
as driving, in which stimuli in the peripheral vision are constantly changing and require
speeded motor responses. The results of the present study indicate that non-tremor onset
patients experience more deficits with these types of visual ADLs than do healthy adults.
Visual Processing Speed
The visual processing speed scale of the VAQ assesses problems performing visual ADLs
that require quickly processing visual information, such as noticing when a car directly in
front is speeding up or slowing down. Although several studies have indicated that PD
patients with an initial symptom other than tremor experience worse overall cognition than
do those presenting with tremor onset (Oh, Kim, Choi, Sohn, & Lee, 2009; Taylor et al.,
2008; Verbaan et al., 2007; Williams et al., 2007; Williams-Gray, Foltynie, Brayne,
Robbins, & Barker, 2007; Zetusky & Jankovic, 1985), ours is the first study demonstrating a
deficit in visual processing speed that is specific to non-tremor patients.
The present study focused on the relation between visual functioning and self-reported
problems with visual ADLs in PD subtypes, finding that the PD subtype with worse visual
functioning (non-tremor symptom onset) also endorsed more problems performing visual
ADLs. This study was not designed to examine the relation between visual ADLs and
cognitive functioning. In this high-functioning sample, subgroups were generally similar on
neuropsychological performance. Further studies using a more comprehensive cognitive
assessment with a larger sample appear warranted to determine whether subtle cognitive
deficits are related to deficits in visual ADLs.
In summary, our results indicated that PD patients with non-tremor symptoms at disease
onset, but not PD participants with tremor at onset, had impairments in visual ADLs,
particularly those involving light/dark adaptation, acuity/spatial vision, depth perception,
peripheral vision and visual processing speed. These findings are in accord with a growing
body of evidence that non-tremor onset PD, relative to the tremor-onset type, is associated
with more extensive cortical and subcortical pathology as well as worse non-motor
symptoms. This is the first study to our knowledge demonstrating that the non-tremor
subtype of PD exhibits greater functional impairment when performing visual ADLs.
Environmental enhancements, such as increasing room lighting and reducing visual clutter,
may help to ameliorate ADL impairments seen in individuals with PD, particularly those
with the non-tremor onset subtype.
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Fig. 1.
Mean total score on the VAQ for NC, Tremor onset PD and Non-tremor onset PD. Error
bars represent standard errors of the mean. The Non-tremor onset PD patients indicated
worse functioning than the NC (p < .017) and Tremor onset PD groups (p < .017).
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Fig. 2.
Mean score for each of the eight scales of the VAQ for NC, Tremor onset PD and Non-
tremor onset PD. Error bars represent standard errors of the mean. The Non-tremor PD
patients indicated worse functioning on the light/dark adaptation, acuity/spatial vision, depth
perception, peripheral vision and visual processing speed subscales than the NC group (p < .
017). Non-tremor PD patients also indicated worse functioning on the light/dark adaptation
and depth subscales (p < .017) than the tremor onset group. VAQ subscales: CD = color
discrimination; GD = glare disability; LDA = light/dark adaptation; ASV = acuity/spatial
Vision; DP = depth perception; PV = peripheral vision; VS = visual search; VPS = visual
processing speed.
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Table 1
Participant characteristics
NC (n = 23) Tremor-onset PD (n = 13) Non-tremor onset PD (n = 12)
Age (yrs) 67.4 (5.4) 66.9 (5.1) 65.3 (5.3)
Education (yrs) 16.7 (1.9) 15.7 (2.1) 17.0 (2.4)
Female: Male 11:12 6:7 6:6
LPD: RPD N/A 7:6 5:7
Hoehn & Yahr stage N/A 1.5 (1–3) 2.0 (1–3)
UPDRS Motor score N/A 35.1 (10.6) 23.4 (9.8)+
UPDRS Rigidity score N/A 6.5 (3.1) 5.3 (4.1)
UPDRS Bradykinesia score N/A 10.3 (4.6) 8.7 (5.0)
UPDRS Tremor score N/A 3.2 (2.3) 1.4 (2.3)
UPDRS Gait score N/A 3.8 (1.1) 3.7 (1.8)
UPDRS Right-side symptoms N/A 7.6 (4.1) 6.6 (3.8)
UPDRS Left-side symptoms N/A 9.8 (4.8) 5.8 (4.0)+
Duration of illness (yrs) N/A 8.9 (5.7) 8.6 (5.8)
Geriatric Depression Scale 3.4 (3.6) 6.3 (4.3)* 6.8 (4.5)*
Cognitive Functioning
Overall mod-MMSE (converted) 28.9 (.73) 27.4 (.82)** 28.0 (1.5)**
Orientation 9.8 (.38) 9.9 (.38) 9.8 (.40)
Registration 3.0 (0.0) 3.0 (0.0) 3.0 (0.0)
Digit Span 10.0 (0.0) 9.5 (.67)** 10.0 (0.0)
Attention and Calculation 6.7 (.58) 5.8 (1.3) 5.7 (1.4)**
Recall 2.7 (.56) 2.2 (1.1) 2.6 (.67)
General Knowledge 4.21 (.79) 3.8 (1.7) 4.1 (1.1)
Naming 9.9 (.32) 9.9 (.38) 9.8 (.43)
Language 6.7 (.46) 6.5 (.66) 6.9 (.29)
Construction 1.95 (.23) 1.92 (.28) 1.75 (.45)
Letter Fluency N/A 15.4 (3.3) 17.4 (3.6)
Category Fluency N/A 19.5 (4.6) 22.7 (6.8)
Longest Digit Span Forward N/A 6.3 (1.3) 7.5 (1.1)+
Longest Digit Span Backward N/A 4.5 (1.2) 5.3 (1.2)
Visual Functioning
Near acuity 20/20 20/25 20/28.5
Far acuity 20/16 20/16 20/20
Near acuity (log-transformed) 0.06 (.13) 0.06 (.13) 0.11 (.19)
Far acuity (log-transformed) −0.03 (.06) −0.03 (.11) 0.03 (.14)
FACT log contrast sensitivity: near
 1.5 cpd 1.95 (.10) 1.98 (.06) 1.87 (.19)
 3.0 cpd 2.10 (.13) 2.11 (.12) 1.93 (.26)**++
 6.0 cpd 2.02 (.20) 2.00 (.29) 1.73 (.34)**
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NC (n = 23) Tremor-onset PD (n = 13) Non-tremor onset PD (n = 12)
 12.0 cpd 1.64 (.32) 1.61 (.32) 1.23 (.32)**+
 18.0 cpd 1.16 (.32) 1.11 (.46) 0.90 (.23)
FACT log contrast sensitivity: far
 1.5 cpd 1.82 (.17) 1.94 (.12) 1.83 (.20)
 3.0 cpd 2.01 (.15) 2.06 (.14) 1.94 (.20)
 6.0 cpd 1.97 (.15) 2.08 (.14) 1.93 (.19)
 12.0 cpd 1.54 (.21) 1.71 (.33) 1.49 (.30)
 18.0 cpd 1.19 (.26) 1.32 (.31) 0.98 (.35)
Note. Values represent means and standard deviations except near and far acuity, which are reported as medians, and Hoehn & Yahr scores, which
are reported in median and range. Hoehn and Yahr stage is an index of motor severity in PD. LPD, RPD: left- and right-onset Parkinson's disease.
FACT = Functional Acuity Contrast Test. UPDRS = Unified Parkinson's Disease Rating Scale. cpd = cycles per degree.
*indicates PD group differed from NC (p < .05);
**indicates PD group differed from NC (p < .017).
+indicates PD groups differed from each other (p < .05);
++indicates PD groups differed from each other (p < .017).
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